desoxycorticosterone acetate has been researched along with Hypertrophy in 7 studies
Desoxycorticosterone Acetate: The 21-acetate derivative of desoxycorticosterone.
Hypertrophy: General increase in bulk of a part or organ due to CELL ENLARGEMENT and accumulation of FLUIDS AND SECRETIONS, not due to tumor formation, nor to an increase in the number of cells (HYPERPLASIA).
| Excerpt | Relevance | Reference |
|---|---|---|
| " The aim of our study was to examine the age-specific influence of the chronic administration of the FAAH inhibitor URB597 on blood pressure (BP), heart rate (HR) and cardiac and renal hypertrophy in hypertensive rats during two critical periods for the development of hypertension." | 1.43 | Age-specific influences of chronic administration of the fatty acid amide hydrolase inhibitor URB597 on cardiovascular parameters and organ hypertrophy in DOCA-salt hypertensive rats. ( Baranowska-Kuczko, M; Grzęda, E; Malinowska, B; Pędzińska-Betiuk, A; Toczek, M; Weresa, J, 2016) |
| "We induced hypertension and hyperlipidemia in landrace pigs (n = 8) by deoxycorticosteroneacetate (DOCA, 100 mg/kg, 90-day-release subcutaneous depot) and a Western diet (WD) containing high amounts of salt, fat, cholesterol, and sugar for 12 wk." | 1.42 | A porcine model of hypertensive cardiomyopathy: implications for heart failure with preserved ejection fraction. ( Alogna, A; Casadei, B; Eller, K; Eller, P; Hamdani, N; Höfler, G; Kirsch, A; Linke, WA; Maechler, H; Manninger, M; Pieske, BM; Post, H; Reilly, S; Schauer, S; Schwarzl, M; Seiler, S; Steendijk, P; Verderber, J; Zirngast, B; Zweiker, D, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Temiz-Resitoglu, M | 1 |
| Guden, DS | 1 |
| Senol, SP | 1 |
| Vezir, O | 1 |
| Sucu, N | 1 |
| Kibar, D | 1 |
| Yılmaz, SN | 1 |
| Tunctan, B | 1 |
| Malik, KU | 1 |
| Sahan-Firat, S | 1 |
| Lee, E | 1 |
| Lee, HA | 1 |
| Kim, M | 1 |
| Do, GY | 1 |
| Cho, HM | 1 |
| Kim, GJ | 1 |
| Jung, H | 1 |
| Song, JH | 1 |
| Cho, JM | 1 |
| Kim, I | 1 |
| Schwarzl, M | 1 |
| Hamdani, N | 1 |
| Seiler, S | 1 |
| Alogna, A | 1 |
| Manninger, M | 1 |
| Reilly, S | 1 |
| Zirngast, B | 1 |
| Kirsch, A | 1 |
| Steendijk, P | 1 |
| Verderber, J | 1 |
| Zweiker, D | 1 |
| Eller, P | 1 |
| Höfler, G | 1 |
| Schauer, S | 1 |
| Eller, K | 1 |
| Maechler, H | 1 |
| Pieske, BM | 1 |
| Linke, WA | 1 |
| Casadei, B | 1 |
| Post, H | 1 |
| Rathee, JS | 1 |
| Patro, BS | 1 |
| Brown, L | 1 |
| Chattopadhyay, S | 1 |
| Toczek, M | 1 |
| Baranowska-Kuczko, M | 1 |
| Grzęda, E | 1 |
| Pędzińska-Betiuk, A | 1 |
| Weresa, J | 1 |
| Malinowska, B | 1 |
| ALICE, C | 1 |
| HUBLE, J | 1 |
7 other studies available for desoxycorticosterone acetate and Hypertrophy
| Article | Year |
|---|---|
Pharmacological Inhibition of Mammalian Target of Rapamycin Attenuates Deoxycorticosterone Acetate Salt-Induced Hypertension and Related Pathophysiology: Regulation of Oxidative Stress, Inflammation, and Cardiovascular Hypertrophy in Male Rats.
Topics: Acetates; Animals; Blood Pressure; Desoxycorticosterone Acetate; Hypertension; Hypertrophy; Inflamma | 2022 |
Upregulation of C/EBPβ and TSC2 by an HDAC inhibitor CG200745 protects heart from DOCA-induced hypertrophy.
Topics: Acetylation; Animals; Cardiotonic Agents; CCAAT-Enhancer-Binding Protein-beta; Desoxycorticosterone | 2019 |
A porcine model of hypertensive cardiomyopathy: implications for heart failure with preserved ejection fraction.
Topics: Animals; Cardiomyopathies; Connectin; Desoxycorticosterone Acetate; Diet, Western; Dilatation, Patho | 2015 |
Mechanism of the anti-hypertensive property of the naturally occurring phenolic, malabaricone C in DOCA-salt rats.
Topics: Animals; Antihypertensive Agents; Antioxidants; Aorta; Desoxycorticosterone Acetate; Disease Models, | 2016 |
Age-specific influences of chronic administration of the fatty acid amide hydrolase inhibitor URB597 on cardiovascular parameters and organ hypertrophy in DOCA-salt hypertensive rats.
Topics: Amidohydrolases; Animals; Benzamides; Blood Pressure; Carbamates; Desoxycorticosterone Acetate; Hear | 2016 |
[Desoxycorticosterone acetate in the treatment of tonsillary hypertrophy].
Topics: Desoxycorticosterone; Desoxycorticosterone Acetate; Disease; Humans; Hyperplasia; Hypertrophy; Lymph | 1955 |
Effects of desoxycorticosterone acetate on chondrogenesis and cartilage hypertrophy in the young chick.
Topics: Animals; Cartilage; Chickens; Chondrogenesis; Desoxycorticosterone; Desoxycorticosterone Acetate; Hu | 1957 |